JPRN-UMIN000033408招募中未知
The longterm outcomes of macular neovascularization treated with intravitreal injections of anti-VEGF drugs - AMD treated by anti-VEGF drugs
agoya University0 个研究点目标入组 300 人开始时间: 2018年7月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 50years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •nothing special
研究者
相似试验
招募中
不适用
Outcomes of macular neovascularization treated with intravitreal injection of Aflibercept with Treat and extendJPRN-UMIN000040311agoya University47
已完成
不适用
Real World Outcomes of Intravitreal Anti-vascular Endothelial Growth Factors for Neovascular Age Related Macular Degeneration in TaiwanAMDNCT03324542Changhua Christian Hospital63
进行中（未招募）
1 期
Managing neovascular age-related macular degeneration over 2 years using of different schedules of 2 mg aflibercept injected in the eye (ARIES)eovascular age-related macular degeneration (nAMD)EUCTR2014-003132-39-FRBayer HealthCare AG268
进行中（未招募）
1 期
Managing neovascular age-related macular degeneration over 2 years using of different schedules of 2 mg aflibercept injected in the eye (ARIES)eovascular age-related macular degeneration (nAMD)EUCTR2014-003132-39-GBBayer AG287
进行中（未招募）
1 期
Managing neovascular age-related macular degeneration over 2 years using of different schedules of 2 mg aflibercept injected in the eye (ARIES)eovascular age-related macular degeneration (nAMD)EUCTR2014-003132-39-ESBayer HealthCare AG268